Discover
RMD
ResMed Inc.
201.10
200 x undefined
100 x undefined
bid
ask
+
6.22
3.19%
150 @ 04:56 AM
202.85 +1.75 (0.87%)
| Ytd | -16.51% | |
| 1y | -21.41% |
197.89
day range
203.22
180.27
52 week range
293.81
| Open | 196.99 | Prev Close | 194.88 | Low | 197.89 | High | 203.22 | Mkt Cap | 29.17B |
| Vol | 875.27K | Avg Vol | 1.42M | EPS | 10.38 | P/E | 19.37 | Forward P/E | 16.10 |
| Beta | 0.78 | Short Ratio | 8.56 | Inst. Own | 70.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 05-14 | Earning | 08-06 | 50-d Avg | 201.95 | 200-d Avg | 239.44 | 1yr Est | 260.60 |
| Income Statement | |||
| Total Revenue | 1.43B | ||
| Revenues (USD) | 1.43B | ||
| Cost of Revenue | 540.43M | ||
| Gross Profit | 890.98M | ||
| Operating Expenses | 391.17M | ||
| Research and Development Expense | 94.27M | ||
| Selling, General and Administrative Expense | 285.65M | ||
| Operating Income | 499.81M | ||
| Interest Expense | -12.29M | ||
| Income Tax Expense | 103.58M | ||
| Net Income | 398.73M | ||
| Net Income Common Stock | 398.73M | ||
| Net Income Common Stock (USD) | 398.73M | ||
| Consolidated Income | 398.73M | ||
| Earnings per Basic Share | 2.74 | ||
| Earnings per Basic Share (USD) | 2.74 | ||
| Earnings per Diluted Share | 2.74 | ||
| Dividends per Basic Common Share | 0.60 | ||
| Earning Before Interest & Taxes (EBIT) | 490.03M | ||
| Earning Before Interest & Taxes (USD) | 490.03M | ||
| Weighted Average Shares | 145.34M | ||
| Weighted Average Shares Diluted | 145.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.66B | ||
| Cash and Equivalents (USD) | 1.66B | ||
| Trade and Non-Trade Receivables | 998.84M | ||
| Current Assets | 4.06B | ||
| Property, Plant & Equipment Net | 728.57M | ||
| Total Assets | 8.78B | ||
| Debt Current | 289.16M | ||
| Total Debt | 843.17M | ||
| Current Liabilities | 1.35B | ||
| Debt Non-Current | 554.01M | ||
| Total Liabilities | 2.29B | ||
| Accumulated Retained Earnings (Deficit) | 6.96B | ||
| Accumulated Other Comprehensive Income | -24.90M | ||
| Shareholders Equity | 6.49B | ||
| Shareholders Equity (USD) | 6.49B | ||
| Assets Non-Current | 4.72B | ||
| Total Debt (USD) | 843.17M | ||
| Deferred Revenue | 342.43M | ||
| Goodwill and Intangible Assets | 3.47B | ||
| Inventory | 911.88M | ||
| Liabilities Non-Current | 941.16M | ||
| Trade and Non-Trade Payables | 273.30M | ||
| Tax Assets | 312.59M | ||
| Tax Liabilities | 241.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 69.03M | ||
| Net Cash Flow from Financing | -255.24M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 243.44M | ||
| Capital Expenditure | -33.65M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -24.88M | ||
| Issuance (Purchase) of Equity Shares | -167.59M | ||
| Payment of Dividends & Other Cash Distributions | -87.24M | ||
| Net Cash Flow from Investing | -58.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.44M | ||
| Net Cash Flow from Operations | 554.13M | ||
| Effect of Exchange Rate Changes on Cash | 2.58M | ||
| Share Based Compensation | 26.79M | ||